Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 560.52K P/E - EPS this Y - Ern Qtrly Grth -
Income -37.19M Forward P/E -0.01 EPS next Y - 50D Avg Chg -27.00%
Sales 1.91M PEG - EPS past 5Y - 200D Avg Chg -98.00%
Dividend N/A Price/Book 0.04 EPS next 5Y - 52W High Chg -100.00%
Recommedations 2.70 Quick Ratio 1.12 Shares Outstanding 58.78M 52W Low Chg 3,900.00%
Insider Own 6.22% ROA -57.59% Shares Float 49.02M Beta 1.95
Inst Own 10.63% ROE -525.78% Shares Shorted/Prior 1.64M/2.97M Price 0.00800
Gross Margin 100.00% Profit Margin - Avg. Volume 576,125 Target Price 3.08
Oper. Margin -2,958.87% Earnings Date Oct 26 Volume 1,105,200 Change -11.11%

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.

GNCA Chatroom

User Image realcon Posted - 2 days ago

$GNCA not on otc anymore? What is EXMKT??

User Image MarketBeat Posted - 2 days ago

Genocea Biosciences initiated by StockNews.com at sell. https://www.marketbeat.com/r/1824685 $GNCA

User Image TwongStocks Posted - 09/28/22

$GNCA Order filed. CEO & CFO were officially let go on Sept 15, but they have been hired back as consultants. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/eaf6b829-7fbb-4511-ba41-da357ace6510_211.pdf They will be advising the company on the potential sale of some HSV-002 antigens from the GEN-003 program. Shionogi had the rights to develop it, but declined the option in 2021. Apparently they started discussions with some 3rd parties about this program. With their lead program, ATLAS, only fetching $2m, not sure how much they can get from this. But there is some hope for now. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/c7294dd0-4809-40ec-ae0c-b02b152cf5ad_199.pdf

User Image mrpres55 Posted - 09/27/22

$GNCA I just bought 10000 shares let’s go

User Image MarketBeat Posted - 09/26/22

Genocea Biosciences initiated by StockNews.com at sell. https://www.marketbeat.com/r/1821994 $GNCA

User Image macroaxis Posted - 09/25/22

$GNCA - Genocea Biosciences max pain price is slipping https://www.macroaxis.com/stock-options/GNCA/Genocea-Biosciences?utm_source=dlvr.it&utm_medium=stocktwits

User Image ajbski Posted - 09/22/22

$GNCA over 5M traded today.

User Image BassmanOH Posted - 09/22/22

$GNCA I can't believe I just found a OTC biotech with an open options chain. I am throwing money at this LOTTO ticket

User Image thirdglasseye Posted - 09/22/22

watching for volume to come in OCGN. histogenics broader pipeline, curing blindness, lancet study, ocu products in TK, DE, CK $NIO bargain downside put opportunity $V bargain downside put opportunity $LCID downside bargain put, trending $ICPT $GNCA

User Image paideia Posted - 09/22/22

$GNCA Looks like another multi-million share day. Hmm.

User Image TwongStocks Posted - 09/21/22

$GNCA Bankruptcy court approves and authorizes the sale of ATLAS assets to Harpy Holdings for $2m. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/2222bdf4-7cf1-4a2e-9748-b3744f5f7fa6_205.pdf Proceeds from the sale will be used to pay the $1.4m secured claim from Silicon Valley Bank. Not much left over from the sale. Remaining unsecured creditors have until Oct 31 to file claims. Next hearing is Sept 28. With the sale completed, CEO William Clark & Chief Scientific Officer Jessica Fletchner were terminated on Sept 15. One of the directors, Craig Jalbert, was appointed as president to oversee completion of Chapter 11. The court hearing is because the company wants to hire Mr. Clark & Ms. Fletchner as consultants on an as-needed basis. Estimated 10-30 hours. Specifically, the company has begun negotiations with 3rd parties for potential monetization of GNCA's interest in a prior joint venture with Shiongi & Co, Ltd. The company anticipates it will need the advice & counsel of Mr. Clark & Ms. Fletchner during those negotiations. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/c7294dd0-4809-40ec-ae0c-b02b152cf5ad_199.pdf

User Image Finscreener Posted - 09/21/22

Penny stocks top winners today $YGYI $MOHO $GNCA $EVAX $KXIN Learn more: https://www.finscreener.org/screener/penny-stocks

User Image Finscreener Posted - 09/21/22

US market Top Gainers during today $SLNG $MOHO $GNCA $EVAX $KXIN Learn more: https://www.finscreener.org/screener/top-gainers/stocks/us-markets

User Image paideia Posted - 09/21/22

$GNCA Almost a $2MM share day. Hmmm.

User Image George1Belgium Posted - 09/21/22

$GNCA Please don't forget, this stock was very strong a year ago, above 1 dollar, this will be back soon!! watch

User Image realcon Posted - 09/21/22

$GNCA big buys before the bell..

User Image TwongStocks Posted - 09/19/22

$GNCA Filing update. The court did not receive any objections or competitive bids to Harpy Holdings' offer to by the ATLAS assets for $2m. The hearing to confirm the sale of their ATLAS assets is set for Sept 21. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/eb9dc1a4-3a4b-43cf-8829-286a6576a50b_195.pdf The non-ATLAS assets were sold earlier to CCRM for $625k. So all of their assets were sold for less than $3m. The bar date for creditors to submit their proof of claims is still Oct 31. After they confirm all of the liabilities, they will determine the next steps. Most likely, they will end up liquidating. Based on earlier filings, their total liabilities easily exceeded $3m. I doubt they will have enough to pay off their remaining debt.

User Image Finscreener Posted - 09/19/22

US markets Stocks with the best potential based on target prices $KLDO $TEUM $GNCA $LLL $AGRX Learn more: https://www.finscreener.org/analysts/target-price-and-potential

User Image MarketBeat Posted - 09/18/22

Genocea Biosciences initiated by StockNews.com at sell. https://www.marketbeat.com/r/1819864 $GNCA

User Image Aigner_Andreas Posted - 09/13/22

#TrendFollowing #TOP10 WK 37 SELL US $GLT $ATTO $FMS $TREE $GNCA NEOG GHL BLL INTC QUOT

User Image topochico78 Posted - 09/12/22

$HGEN Humanigen is my bullshit market indicator. If this is up, you know the pump is bullshit $SPY same with $GNCA

User Image Finscreener Posted - 09/12/22

US markets Stocks with the best potential based on target prices $KLDO $TEUM $YGYI $GNCA Learn more: https://www.finscreener.org/analysts/target-price-and-potential

User Image MarketBeat Posted - 09/10/22

Genocea Biosciences initiated by StockNews.com at sell. https://www.marketbeat.com/r/1817376 $GNCA

User Image Invescent Posted - 09/07/22

Overall A has given $GNCA Neutral Rating . When analysing the financial scores the results are as followed: PiotroskiScore: 0.0 Rating Score: 3 DCF Score 5 ROA Score: 1 PB Score : 5 PE Score: 5 Simplify the way you do research and look for stocks with Invescent https://play.google.com/store/apps/details?id=org.invescentpro.invescent

User Image MarketBeat Posted - 1 month ago

Genocea Biosciences initiated by StockNews.com at sell. https://www.marketbeat.com/r/1814947 $GNCA

User Image TwongStocks Posted - 1 month ago

$GNCA Couple new court filings. The bar date for claims is set for Oct 31st. This is the deadline to submit any claims against the company. So the bankruptcy process isn't going to be finished anytime soon. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/8708aca3-470b-43ef-b9a5-59bf30e47c63_190.pdf They also filed their monthly operating report for July. https://casedocs.omniagentsolutions.com/cmsvol2/pub_47448/b3133bd8-34f0-4f12-8062-e21257fb8a61_189.pdf As of July 31st, they had: $9,719,171 in total assets (includes $813,308 cash) $11,025,399 in total liabilities $-1,306,228 in equity

User Image Stocks4thought Posted - 08/30/22

$GNCA chip is on linkedin- talking about- maybe new venture- ask if he will pay us all back th $100,000 he lost people. F chip

User Image mrpres55 Posted - 08/30/22

$PSNL it’s a buy below 1 For a quick rally , this is $GNCA

User Image Finscreener Posted - 08/30/22

US markets Stocks with the best potential based on target prices $KLDO $TEUM $GNCA $YGYI $PIXY Learn more: https://www.finscreener.org/analysts/target-price-and-potential

User Image Invescent Posted - 08/27/22

Overall Analyst has given $GNCA Neutral Rating . When analysing the financial scores the results are as followed: PiotroskiScore: 0.0 Rating Score: 3 DCF Score 5 ROA Score: 1 PB Score : 5 PE Score: 5 Simplify the way you do research and look for stocks with Invescent https://play.google.com/store/apps/details?id=org.invescentpro.invescent

Analyst Ratings
HC Wainwright & Co. Neutral Apr 29, 22
Stifel Hold Apr 29, 22
SVB Leerink Outperform Apr 6, 21
Needham Buy Feb 11, 21
Needham Buy Nov 25, 20
HC Wainwright & Co. Buy Nov 25, 20
SVB Leerink Outperform Nov 25, 20
H.C. Wainwright Buy Nov 25, 20
Cantor Fitzgerald Overweight Nov 25, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Walker Paul Edward 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
Sonsini Peter W. 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
SANDELL SCOTT D 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
New Enterprise Associates 16,... 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
Makhzoumi Mohamad 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
Florence Anthony A. Jr. 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
Chang Carmen 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
Behbahani Ali Director Director May 24 Sell 0.07 10,376,936 726,386 05/26/22
BASKETT FOREST 10% Owner 10% Owner May 24 Sell 0.07 10,376,936 726,386 05/26/22
Flechtner Jessica Baker Chief Scientific Off.. Chief Scientific Officer Apr 04 Sell 1.25 1,212 1,515 96,193 04/05/22
Duvall Diantha CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Apr 04 Sell 1.25 963 1,204 91,775 04/05/22
Davis Thomas Andrew CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Apr 04 Sell 1.25 1,091 1,364 68,330 04/05/22
Clark William D President and CEO President and CEO Apr 04 Sell 1.25 3,924 4,905 369,487 04/05/22
Aakalu Girish N CHIEF BUSINESS OFFIC.. CHIEF BUSINESS OFFICER Apr 04 Sell 1.25 963 1,204 74,459 04/05/22
Aakalu Girish N CHIEF BUSINESS OFFIC.. CHIEF BUSINESS OFFICER Mar 15 Sell 1.1 2,397 2,637 75,422 03/17/22